SEC Form 4 · accession 0001127602-15-031297
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martine A Rothblatt
Officer — Chairman & Co-CEO · Director
Period of report
Nov 12, 2015
Accepted (ET)
Nov 13, 2015 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Nov 12, 2015 | M | 5,546 | $30.75 | A | 5,786 | D | |
| Common Stock | Nov 12, 2015 | S | 100 | $143.69 | D | 5,686 | D | |
| Common StockF3 | Nov 12, 2015 | S | 3,061 | $146.7673 | D | 2,625 | D | |
| Common StockF4 | Nov 12, 2015 | S | 2,185 | $147.5884 | D | 440 | D | |
| Common Stock | Nov 12, 2015 | S | 100 | $148.66 | D | 340 | D | |
| Common Stock | Nov 12, 2015 | S | 100 | $149.33 | D | 240 | D | |
| Common Stock | holding | — | — | — | 166 | I | By Spouse | |
| Common Stock | holding | — | — | — | 625,031 | I | By Trusts |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $30.75 | Nov 12, 2015 | M | 5,546 | D | Dec 26, 2009 | Dec 31, 2017 | Common Stock | 5,546 | 327,240 | D |
Explanation of responses
- F1This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
- F2Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.
- F3This transaction was executed in multiple trades at prices ranging from $146.24 to $147.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $147.24 to $148.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.